David C. Myles's most recent trade in Olema Pharmaceuticals Inc was a trade of 250,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 106,250 | 106,250 | - | - | Performance Stock Options (Right to Buy) | |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.87 per share. | 12 Jan 2026 | 50,000 | 592,761 | - | 4.9 | 243,500 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.87 per share. | 12 Jan 2026 | 50,000 | 592,761 | - | 4.9 | 243,500 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 50,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 27.60 per share. | 12 Jan 2026 | 49,800 | 542,961 | - | 27.6 | 1,374,480 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 28.99 per share. | 12 Jan 2026 | 35,003 | 542,761 | - | 29.0 | 1,014,737 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 28.60 per share. | 12 Jan 2026 | 14,997 | 577,764 | - | 28.6 | 428,914 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 28.34 per share. | 12 Jan 2026 | 10,000 | 144,846 | - | 28.3 | 283,400 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 28.49 per share. | 12 Jan 2026 | 200 | 542,761 | - | 28.5 | 5,698 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 30.40 per share. | 19 Dec 2025 | 43,729 | 557,927 | - | 30.4 | 1,329,362 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 9,000 | 542,881 | - | 0 | Common Stock | |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 31.39 per share. | 19 Dec 2025 | 6,046 | 551,881 | - | 31.4 | 189,784 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 28.08 per share. | 19 Dec 2025 | 1,225 | 601,656 | - | 28.1 | 34,398 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 205,000 | 205,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 48,750 | 624,399 | - | 0 | Common Stock | |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 8.66 per share. | 09 Dec 2024 | 13,314 | 598,633 | - | 8.7 | 115,299 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 9.38 per share. | 09 Dec 2024 | 12,452 | 611,947 | - | 9.4 | 116,800 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 9.39 per share. | 09 Dec 2024 | 300 | 598,333 | - | 9.4 | 2,817 | Common Stock |
| Olema Pharma Inc | C. David Myles | CH. DISCOV. & NON-CLIN DEV OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 26,250 | 587,728 | - | 0 | Common Stock | |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 14.87 per share. | 20 Nov 2023 | 6,776 | 580,952 | - | 14.9 | 100,759 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 20 Nov 2023 | 6,653 | 574,099 | - | 13.9 | 92,410 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 15.32 per share. | 20 Nov 2023 | 200 | 580,752 | - | 15.3 | 3,064 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 17.61 per share. | 08 Nov 2023 | 200 | 561,270 | - | 17.6 | 3,522 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 01 Nov 2023 | 6,668 | 565,343 | - | 15.0 | 100,153 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 15.36 per share. | 01 Nov 2023 | 3,332 | 562,011 | - | 15.4 | 51,180 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 17.51 per share. | 01 Nov 2023 | 541 | 561,470 | - | 17.5 | 9,473 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 12.67 per share. | 19 Sep 2023 | 20,000 | 572,011 | - | 12.7 | 253,400 | Common Stock |
| Olema Pharma Inc | David C. Myles | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | David C. Myles | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 118,750 | 118,750 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | David C. Myles | CHIEF DEVELOPMENT OFFICER | Sale of securities on an exchange or to another person at price $ 10.30 per share. | 10 Dec 2021 | 10,000 | 582,901 | - | 10.3 | 103,000 | Common Stock |